Download presentation
Presentation is loading. Please wait.
Published by壁 晏 Modified over 5 years ago
1
Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea Xuereb, BS, Babbaljeet Kaur, MD, Silvy Akrawe, BS, Hassan W. Nemeh, MD, Jamil Borgi, MD, David E. Lanfear, MD, MS, Celeste T. Williams, MD, Gaetano Paone, MD The Annals of Thoracic Surgery Volume 102, Issue 4, Pages (October 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Kaplan-Meier survival curve for all patients receiving continuous-flow left ventricular assist devices (LVADs). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Comparison of Kaplan-Meier survival between bridge to transplantation (BTT) and destination therapy (DT) patients. (LVAD = left ventricular assist device.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
4
Fig 3 Competing outcomes curve for all patients receiving continuous-flow left-ventricular assist devices: ongoing or received a transplant, ongoing support, received a transplant, or death. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.